Brooks Lab.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE650L01011
  • NSEID: BROOKS
  • BSEID: 533543
INR
56.38
1.61 (2.94%)
BSENSE

May 06

BSE+NSE Vol: 2.62 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 539063,
    "name": "Brooks Lab.",
    "stock_name": "Brooks Lab.",
    "full_name": "Brooks Laboratories Ltd",
    "name_url": "stocks-analysis/brooks-lab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "56.38",
    "chg": 1.61,
    "chgp": "2.94%",
    "dir": 1,
    "prev_price": "54.77",
    "mcapval": "163.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 533543,
    "symbol": "BROOKS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE650L01011",
    "curr_date": "May 06",
    "curr_time": "",
    "bse_nse_vol": "2.62 lacs",
    "exc_status": "Active",
    "traded_date": "May 06, 2026",
    "traded_date_str": "2026 05 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/brooks-lab-539063-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Brooks Laboratories Ltd Locks at Upper Circuit With 4.94% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brooks-laboratories-ltd-hits-upper-circuit-amid-strong-buying-pressure-3977916",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BrooksLaborator_stocks_hitting_upper_circuit_3977916.png",
        "date": "2026-05-06 13:00:07",
        "description": "At Rs 56.97, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Brooks Laboratories Ltd locked at its upper circuit of 4.94% on 6 May 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Brooks Laboratories Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brooks-laboratories-ltd-hits-upper-circuit-amid-strong-buying-pressure-3974104",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BrooksLaborator_stocks_hitting_upper_circuit_3974104.png",
        "date": "2026-05-04 13:00:06",
        "description": "At Rs 58.77, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Brooks Laboratories Ltd locked at its upper circuit of 4.98% on 4 May 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Below All Moving Averages and Now at Lower Circuit: Brooks Laboratories Ltd Loses 4.52% in a Single Session",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brooks-laboratories-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3968487",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BrooksLaborator_stocks_hitting_lower_circuit_3968487.png",
        "date": "2026-04-29 15:00:06",
        "description": "At Rs 58.7, sellers were still queuing — but there were no buyers willing to take the other side. Brooks Laboratories Ltd locked at its lower circuit of 5% on 29 Apr 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in a micro-cap stock with limited liquidity."
      },
      {
        "title": "Brooks Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/brooks-laboratories-ltd-is-rated-sell-3966410",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BrooksLaborator_mojoScore_3966410.png",
        "date": "2026-04-28 10:10:39",
        "description": "Brooks Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Brooks Laboratories Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brooks-laboratories-ltd-hits-upper-circuit-amid-strong-buying-pressure-3959505",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BrooksLaborator_stocks_hitting_upper_circuit_3959505.png",
        "date": "2026-04-23 15:00:06",
        "description": "At Rs 64.36, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Brooks Laboratories Ltd locked at its upper circuit of 4.99% on 23 Apr 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Brooks Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/brooks-laboratories-ltd-is-rated-sell-3950702",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BrooksLaborator_mojoScore_3950702.png",
        "date": "2026-04-17 10:10:40",
        "description": "Brooks Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 17 April 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Brooks Laboratories Ltd Locks at Upper Circuit With 20% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brooks-laboratories-ltd-surges-20-to-hit-upper-circuit-amid-robust-buying-pressure-3934571",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BrooksLaborator_stocks_hitting_upper_circuit_3934571.png",
        "date": "2026-04-06 15:00:07",
        "description": "At Rs 64.05, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Brooks Laboratories Ltd locked at its upper circuit of 19.99% on 6 Apr 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Brooks Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/brooks-laboratories-ltd-is-rated-sell-3934100",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BrooksLaborator_mojoScore_3934100.png",
        "date": "2026-04-06 10:10:39",
        "description": "Brooks Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and technical outlook."
      },
      {
        "title": "Brooks Laboratories Gains 24.05%: 2 Key Events Driving the Volatile Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brooks-laboratories-gains-2405-2-key-events-driving-the-volatile-week-3932247",
        "imagepath": "",
        "date": "2026-04-04 17:02:50",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Mar 30:</strong> New 52-week low (Rs.37.49)</p>\n                    <p><strong>Apr 01:</strong> Upper circuit hit with 19.98% gain (Rs.44.98)</p>\n                    <p><strong>Apr 02:</strong> Continued strong rally to Rs.53.69 (+19.36%)</p>\n                    <p><strong>Apr 03:</strong> No trading data available</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.37.49</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.53.69</div><div class=\"stat-change positive\">+43.23%</div></div>\n  ..."
      }
    ],
    "total": 298,
    "sid": "539063",
    "stock_news_url": "https://www.marketsmojo.com/news/brooks-laboratories-539063"
  },
  "announcements": [
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "29-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Brooks Laboratories Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24232HP2002PLC000267</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>1.19</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>CAREBBSTABLECAREA4</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>CARE RATINGS LIMITED</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: KRUTIKA MOHAN RANE <br/> Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER <br/> EmailId: cs@brookslabs.net</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: PRASHANT RATHI <br/> Designation: CHIEF FINANCIAL OFFICER <br/> EmailId: cfo@brookslabs.net</div> </div> <div> <br/> Date: 29/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "10-Apr-2026",
      "details": "Certificate under Regulation 74(5) of SEBI(DP) Regulation 2018 for quarter ended 31st March 2026.",
      "source": "BSE"
    },
    {
      "caption": "Reply To Clarification Sought Vide Email Dated 1St April 2026 With Reference To Price Movement.",
      "datetime": "02-Apr-2026",
      "details": "Reply to clarification sought vide email dated 1st April 2026 with reference to Price Movement.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Brooks Laboratories Ltd has announced <strong>1:16</strong> rights issue, ex-date: 28 Jul 23",
          "dt": "2023-07-28",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

29-Apr-2026 | Source : BSE

Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1Name of CompanyBrooks Laboratories Ltd
2CIN NO.L24232HP2002PLC000267
3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) 1.19
4Highest Credit Rating during the previous FY CAREBBSTABLECAREA4
4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CARE RATINGS LIMITED
5Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the frameworkBSE


We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No



Name of the Company Secretary: KRUTIKA MOHAN RANE
Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER
EmailId: cs@brookslabs.net
Name of the Chief Financial Officer: PRASHANT RATHI
Designation: CHIEF FINANCIAL OFFICER
EmailId: cfo@brookslabs.net

Date: 29/04/2026

Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

10-Apr-2026 | Source : BSE

Certificate under Regulation 74(5) of SEBI(DP) Regulation 2018 for quarter ended 31st March 2026.

Reply To Clarification Sought Vide Email Dated 1St April 2026 With Reference To Price Movement.

02-Apr-2026 | Source : BSE

Reply to clarification sought vide email dated 1st April 2026 with reference to Price Movement.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Brooks Laboratories Ltd has announced 1:16 rights issue, ex-date: 28 Jul 23